|
Market Closed -
Nasdaq
00:00:00 31/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.7119 USD | -1.68% |
|
-4.53% | -37.55% |
| 10-26 | Top Premarket Gainers | MT |
| 10-12 | Iridex Says Glaucoma Therapy Lowers Eye Pressure, Reduces Medication Use | MT |
Evolution of the Average Target: IRIDEX Corporation
Evolution of the Target Price: IRIDEX Corporation
Changes in Analyst Recommendations: IRIDEX Corporation
5296c68c276cd44872cfa9.dZtTzPxqiwblv0dxuaGyswVxvzgn_204l5dwnZKDbW4.Q9cE-4wM4kHR6QQo3NTw51oj5UlyuQEO5f8graLUHlY68jmIyD_JZLbYKA~593d90f79920a315ea3eeecb8d8ce76f
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +286.29% | |||
| +7.91% | |||||
| +11.92% | |||||
| +11.72% | |||||
| +22.06% | |||||
| +5.84% | |||||
| +10.71% | |||||
| -3.79% | |||||
| +4.11% | |||||
| +0.68% | |||||
| Average | +35.74% | |||||
| Weighted average by Cap. | +9.06% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.7119USD
Average target price
2.750USD
Spread / Average Target
+286.29%
High Price Target
2.750USD
Spread / Highest target
+286.29%
Low Price Target
2.750USD
Spread / Lowest Target
+286.29%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- IRIX Stock
- Consensus IRIDEX Corporation
Select your edition
All financial news and data tailored to specific country editions
